Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Journal of Applied Pharmaceutical Research
Rane, Bhushan R.
Unknown Affiliation
Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Exploring the potential of carbocisteine loaded microparticulate system by using ccd model for the treatment of respiratory infections Rane, Bhushan R.; Gavit, Mayur R; Patil, Vaibhav L; Mhatre, Nandini R; Jain, Ashish S
Journal of Applied Pharmaceutical Research Vol. 12 No. 3 (2024)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v12i3.562

Abstract

Background: Multi-particulate drug delivery systems (microbeads) deliver drugs over an extended period, distributing them evenly throughout the gastrointestinal tract and minimizing local irritation. Microbeads are small, solid, free-flowing particulate carriers that contain drug particles that have been dispersed and are either crystalline in solution. Aim: The present work explores the potential of the carbocisteine-loaded floating microparticulate drug delivery system. Methodology: Floating microbeads were prepared using the ionotropic gelation method and optimized using Central Composite Design. Result and discussion: Floating microbeads of prepared carbocisteine were evaluated for the FTIR study, which reveals no interaction between the drug and other excipients. Buoyancy time, drug content, particle size, and % drug release were also characterized; it found that drug release was 90.24 %, up to 17 hours, 250 to 220 µm, and drug content 96.67%, respectively, for the optimized batch. An accelerated stability study was performed, showing that the formulation was stable. Floating microparticulate drugs were prepared, and batch B-3 was optimized based on in-vitro buoyancy and release patterns. The floating ability of the beads was observed visually for 10 to 17 hr, and an increase in polymer concentration decreased the swelling of the beads. Conclusion: The results obtained from the formulation batch B-3 show good results for all the parameters tested. Floating microbeads could be the best possible approach to deliver drugs with the benefit of reduced dosing frequency
Fabrication and evaluation of carbocisteine-loaded solid lipid nanoparticles to treat pulmonary infections Rane, Bhushan R.; Jain, Ashish S.; Mane, Nikita P.; Patil, Vaibhav; Patil, Mukesh S.; Bavaskar, Kedar R.
Journal of Applied Pharmaceutical Research Vol. 12 No. 6 (2024)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v12i6.661

Abstract

Background:  Solid lipids Nanoparticles (SLN) comprise physiological and biocompatible lipids. SLN is an alternative carrier system to polymeric nanoparticles or liposomes. It has been claimed that SLN offers combined advantages and avoids the disadvantages of other colloidal carrier systems. Aim: The research aims to fabricate and evaluate the carbocisteine solid lipid nanoparticles loaded in situ gel. Methodology:  SLN was prepared by using glycerol monostearate as a solid lipid and by high-pressure homogenization (Panda plus 2000) method using poloxamer 188 as a stabilizer to improve its bioavailability and reduce particle size. The quality-by-design concept was used to develop the SLN by optimizing process variables. Result and discussion: The drug and excipient compatibility study was checked using FTIR, and no interaction between both was found. Optimized SLN of carbocisteine were evaluated for zeta potential, particle size, and % drug release, found results as -19.67 mv, 50 to 200 nm, and up to 70.84%, respectively. Optimized gel batches were also evaluated for the stability study. Conclusion: All the batches were evaluated for various parameters. The F6 batch was optimized based on particle size, stability, Zeta potential, and release pattern. SLN could provide a better advantage of good penetration and targeting to treat pulmonary disease.
Co-Authors Bavaskar, Kedar R. Gavit, Mayur R Jain, Ashish S Jain, Ashish S. Mane, Nikita P. Mhatre, Nandini R Patil, Mukesh S. Patil, Vaibhav Patil, Vaibhav L